These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7531144)

  • 1. Recombinant CD4-IgE, a novel hybrid molecule, inducing basophils to respond to human immunodeficiency virus (HIV) and HIV-infected target cells.
    Krauss S; Kufer P; Federle C; Tabaszewski P; Weiss E; Rieber EP; Riethmüller G
    Eur J Immunol; 1995 Jan; 25(1):192-9. PubMed ID: 7531144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
    Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
    Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo.
    Haak-Frendscho M; Ridgway J; Shields R; Robbins K; Gorman C; Jardieu P
    J Immunol; 1993 Jul; 151(1):351-8. PubMed ID: 7686940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular interactions of IgE: towards a new function for IgE].
    Dessaint JP; Capron A
    Pathol Biol (Paris); 1980 Nov; 28(9):605-16. PubMed ID: 7003508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.
    MacGlashan DW; Bochner BS; Adelman DC; Jardieu PM; Togias A; McKenzie-White J; Sterbinsky SA; Hamilton RG; Lichtenstein LM
    J Immunol; 1997 Feb; 158(3):1438-45. PubMed ID: 9013989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW; Demissie S; Thomas D; Daëron M
    Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE regulates mouse basophil Fc epsilon RI expression in vivo.
    Lantz CS; Yamaguchi M; Oettgen HC; Katona IM; Miyajima I; Kinet JP; Galli SJ
    J Immunol; 1997 Mar; 158(6):2517-21. PubMed ID: 9058781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.
    Daëron M; Malbec O; Latour S; Arock M; Fridman WH
    J Clin Invest; 1995 Feb; 95(2):577-85. PubMed ID: 7860741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IgE-mediated allergy and Fc epsilon receptor II].
    Suemura M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1427-33. PubMed ID: 1434215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early expression of high-affinity receptor for immunoglobulin E (Fc epsilon RI) during differentiation of mouse mast cells and human basophils.
    Thompson HL; Metcalfe DD; Kinet JP
    J Clin Invest; 1990 Apr; 85(4):1227-33. PubMed ID: 2138633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid residues that influence Fc epsilon RI-mediated effector functions of human immunoglobulin E.
    Sayers I; Cain SA; Swan JR; Pickett MA; Watt PJ; Holgate ST; Padlan EA; Schuck P; Helm BA
    Biochemistry; 1998 Nov; 37(46):16152-64. PubMed ID: 9819207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of an Fcgamma-Fc(epsilon)-fusion protein in house dust mite sensitive nonhuman primates.
    Van Scott MR; Mertsching E; Negrou E; Miles J; Stallings HW; Graff C; Kehry MR
    Clin Immunol; 2008 Sep; 128(3):340-8. PubMed ID: 18583194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of IgE-dependent histamine release from human peripheral blood basophils by humanized Fab fragments that recognize the membrane proximal domain of the human Fc epsilon RI alpha-chain.
    Takai T; Yuuki T; Ra C
    Int Arch Allergy Immunol; 2000 Dec; 123(4):308-18. PubMed ID: 11146388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mast-cell and basophil function and survival by IgE.
    Kawakami T; Galli SJ
    Nat Rev Immunol; 2002 Oct; 2(10):773-86. PubMed ID: 12360215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
    Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
    J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.
    Zhu D; Kepley CL; Zhang M; Zhang K; Saxon A
    Nat Med; 2002 May; 8(5):518-21. PubMed ID: 11984598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of IgE elevation in HIV-1 infection.
    Marone G; Florio G; Triggiani M; Petraroli A; de Paulis A
    Crit Rev Immunol; 2000; 20(6):477-96. PubMed ID: 11396683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of soluble Fc epsilon receptor II (sFc epsilon RII/CD23) in serum and possible application of sFc epsilon RII for the prevention of allergic reactions.
    Suemura M; Kikutani H; Sugiyama K; Uchibayashi N; Aitani M; Kuritani T; Barsumian EL; Yamatodani A; Kishimoto T
    Allergy Proc; 1991; 12(3):133-7. PubMed ID: 1716601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric Fc receptors identify immunoglobulin-binding regions in human Fc gamma RII and Fc epsilon RI.
    Hulett MD; McKenzie IF; Hogarth PM
    Eur J Immunol; 1993 Mar; 23(3):640-5. PubMed ID: 8449212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificity.
    Sun LK; Liou RS; Sun NC; Gossett LA; Sun C; Davis FM; MacGlashan DW; Chang TW
    J Immunol; 1991 Jan; 146(1):199-205. PubMed ID: 1701791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.